SW 780 In Vitro BrdU Assay (Cell Proliferation) (CAT#: ITS-1022-YF3059)

SW 780

Human

The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma.

SW-780, SW780

Bladder Cancer

Oncology

In Vitro BrdU Assay (Cell Proliferation)

SW 780-cell based In Vitro BrdU Assay (Cell Proliferation)

5-Bromo-2'-deoxyuridine (BrdU) assay is another methodological approach used to determine cell proliferation. BrdU incorporated into synthesized DNA can be determined using BrdU-specific monoclonal antibody. A secondary antibody is used to generate fluorescent signal on DNA synthesis.

5-Bromo-2'-deoxyuridine (BrdU) Assay

Cell Viability/Cytotoxicity and Antiproliferative Assays

Uncontrolled proliferation is one of the main features of cancer cells. Cell-based in vitro assays are employed to determine whether test molecules possess direct cytotoxic/antiproliferative effects in cancer cells.

Cell Proliferation Assay

Cell-based Assays Based on DNA Synthesis